Direktorat Registrasi ObatValid

ZOLGENSMA

Claim this product
BPOM Number
DKI2672000149A1
Approved
24 June 2026
Expiry
24 June 2031
Form
LARUTAN UNTUK INFUS INTRAVENA

About This Registration

ZOLGENSMA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2672000149A1. Its current registration status is Valid, with the licence valid until 24 June 2031. The product is registered to NOVARTIS INDONESIA - INDONESIA. BPOM first approved this registration in June 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 30 June 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, VIAL 5.5 ML DAN/ATAU VIAL 8.3 ML
Department
Direktorat Registrasi Obat
Data Last Updated
30 June 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

ONASEMNOGENE ABEPARVOVEC

Market Intelligence

Owner Portfolio
NOVARTIS INDONESIA - INDONESIA holds 142 BPOM registrations
Manufacturer Scale
NOVARTIS INDONESIA - INDONESIA produces 142 registered products
Registration Age
Registered for 2 months
Update Status
Recently updated (69 days ago)

FDA Cross-Reference

via openFDA
Generic Name
ONASEMNOGENE ABEPARVOVEC-XIOI
Product Type
HUMAN PRESCRIPTION DRUG

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from NOVARTIS INDONESIA - INDONESIA

TASIGNA

-DKI2621002001A1
Valid
Approved: May 24, 2026KAPSUL
View product →

EXFORGE 5/80

-DKI2601700617A1
Valid
Approved: Apr 16, 2026TABLET SALUT SELAPUT
View product →

EXFORGE 10/160

-DKI2601700617C1
Valid
Approved: Apr 16, 2026TABLET SALUT SELAPUT
View product →

SANDOSTATIN LAR

-DKI2281602044B1
Valid
Approved: Dec 31, 2025SERBUK INJEKSI + PELARUT
View product →

TYKERB

-DKI2057000117A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

ULSIDEX

-DKL8505001710A1
Valid
Approved: Aug 16, 2026TABLET
DEXA MEDICA - INDONESIA
View product →

OB COMBI ANTITUSSIVE

-DTL1904134737A1
Valid
Approved: Jan 23, 2026SIRUP
COMBIPHAR
View product →

FONTREXED

-DKL2041501144B1
Valid
Approved: Jan 15, 2026SERBUK INJEKSI LIOFILISASI
FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA
View product →

OCTANATE 1000 IU

-DKI1409300744B1
Valid
Approved: Jan 7, 2026SERBUK INJEKSI
HARSEN LABORATORIES - INDONESIA
View product →

LEVEXA

-DKL2043501617B1
Valid
Approved: Dec 11, 2025TABLET SALUT SELAPUT
AMAROX PHARMA GLOBAL - INDONESIA
View product →
1